Search research articles
Contact Us
Filters
Showing results (81-90 of 102) with videos related to
Page
of 11
Sort By:
Cell Death & Disease
|
June 6, 2024
Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages
Changjian Zhu, Ruilin Zheng, Xu Han, et al.
Cancer Medicine
|
March 14, 2019
Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
Shuling Chen, Huilin Jin, Zihao Dai, et al.
Eclinicalmedicine
|
September 5, 2022
Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial
Yan Wang, Chengtao Wang, Shasha He, et al.
Radiology. Imaging Cancer
|
September 5, 2025
Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization
Ran Wei, Zelong Liu, Lingjie Ju, et al.
Annals of Surgical Oncology
|
May 20, 2020
Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A
Mengchao Wei, Shuling Chen, Jiali Li, et al.
Nature Structural & Molecular Biology
|
November 4, 2025
TRIM21 and OTUD6A orchestrate AKT K27-linked atypical ubiquitination to modulate cancer chemoresistance
Qiwei Jiang, Peipei Song, Shuishen Zhang, et al.
Liver Cancer
|
April 2, 2026
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study
Nan Jiang, Wen Zhang, Zhenwei Peng, et al.
Hepatobiliary Surgery and Nutrition
|
June 11, 2026
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation
Bin-Yan Zhong, Zhongzhi Jia, Ho-Young Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2022
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
Zhenwei Peng, Wenzhe Fan, Bowen Zhu, et al.
The Journal of Clinical Investigation
|
January 8, 2025
Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice
Shuang Chen, Chensong Huang, Kang Li, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 102) with videos related to
Sort By:
Page
of 11
Cell Death & Disease
|
June 6, 2024
Knockout of integrin αvβ6 protects against renal inflammation in chronic kidney disease by reduction of pro-inflammatory macrophages
Changjian Zhu, Ruilin Zheng, Xu Han, et al.
Cancer Medicine
|
March 14, 2019
Liver resection versus transarterial chemoembolization for the treatment of intermediate-stage hepatocellular carcinoma
Shuling Chen, Huilin Jin, Zihao Dai, et al.
Eclinicalmedicine
|
September 5, 2022
Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label, noninferiority, multicentre, randomised, controlled phase 3 trial
Yan Wang, Chengtao Wang, Shasha He, et al.
Radiology. Imaging Cancer
|
September 5, 2025
Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization
Ran Wei, Zelong Liu, Lingjie Ju, et al.
Annals of Surgical Oncology
|
May 20, 2020
Prognostic Role of Time to Surgery in Hepatocellular Carcinoma at Barcelona Clinic Liver Cancer Stage 0-A
Mengchao Wei, Shuling Chen, Jiali Li, et al.
Nature Structural & Molecular Biology
|
November 4, 2025
TRIM21 and OTUD6A orchestrate AKT K27-linked atypical ubiquitination to modulate cancer chemoresistance
Qiwei Jiang, Peipei Song, Shuishen Zhang, et al.
Liver Cancer
|
April 2, 2026
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study
Nan Jiang, Wen Zhang, Zhenwei Peng, et al.
Hepatobiliary Surgery and Nutrition
|
June 11, 2026
Precision transarterial chemoembolization in hepatocellular carcinoma: patient selection, standardized techniques, and quantitative evaluation
Bin-Yan Zhong, Zhongzhi Jia, Ho-Young Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2022
Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
Zhenwei Peng, Wenzhe Fan, Bowen Zhu, et al.
The Journal of Clinical Investigation
|
January 8, 2025
Tumor-initiating cells escape tumor immunity via CCL8 from tumor-associated macrophages in mice
Shuang Chen, Chensong Huang, Kang Li, et al.
Page
of 11